Biomarkers and Genomic Testing
Tools You Can Use
Liquid Biopsy/ctDNA Testing: Signatera
Liquid Biopsy/ctDNA (for MRD) Testing: Guardant Reveal
Liquid Biopsy/ctDNA Testing: Guardant360®
Tissue Testing: Immunoscore®
Questions? Feedback?

Signatera video resources

Signatera patient testimonial: colorectal cancer care virtual Town Hall:

Hear colorectal cancer patient Angela Gengler share her experience with COVID-19 and how it impacted her surveillance plan. Her doctor was able to order mobile Signatera so that she could have her biopsy drawn from home. 

Patient story: unexplained elevated CEA

Brooks, a young-onset patient, talks about her experience with Signatera.

Patient story: is my cancer recurring?

Casey talks about her experience using Signatera to detect molecular residual disease (MRD)

ctDNA and MRD testing | colorectal cancer care tools for surveillance: 

Listen as Alexey Aleshin, MD, Gregory Botta, MD, PhD, Sarah Louden, and Manju George, DVM, PhD, dive into tools for surveillance that directly impact colorectal cancer care, including ctDNA and MRD testing.

 A ctDNA assay for remote monitoring and risk stratification:

Presented by Dr. Alexey Aleshin, Natera’s senior medical director of oncology. 

For each featured testing option, we have worked with the test provider to describe , We continue to add new sections over time, so be sure to check back often!

  • When the test can be used – what stage, treatment status, etc.
  •  A clear explanation of what you will learn and how to use the data with your care team
  • How you can access the test, and get it paid for

You can find more information online and at the Signatera blog.

Questions about Signatera? Email [email protected] or call +1.650.489.9050